Maurizio Galderisi (31 August 1954-27 March 2020).

Eur Heart J

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Published: July 2020

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehaa268DOI Listing

Publication Analysis

Top Keywords

maurizio galderisi
4
galderisi august
4
august 1954-27
4
1954-27 march
4
march 2020
4
maurizio
1
august
1
1954-27
1
march
1
0
1

Similar Publications

Aim: we sought to test the inter-center reproducibility of 16 echo laboratories involved in the EACVI-Afib Echo Europe.

Methods: This was done on a dedicated setting of 10 patients with sinus rhythm (SR) and 10 with persistent atrial fibrillation (AF), collected by the Principal Investigator. Images and loops of echo-exams were stored and made available for labs.

View Article and Find Full Text PDF

Multimodality imaging approach to left ventricular dysfunction in diabetes: an expert consensus document from the European Association of Cardiovascular Imaging.

Eur Heart J Cardiovasc Imaging

January 2022

IMRB - Inserm U955 Senescence, metabolism and cardiovascular diseases 8, rue du Général Sarrail, 94010 Créteil, France.

Heart failure (HF) is among the most important and frequent complications of diabetes mellitus (DM). The detection of subclinical dysfunction is a marker of HF risk and presents a potential target for reducing incident HF in DM. Left ventricular (LV) dysfunction secondary to DM is heterogeneous, with phenotypes including predominantly systolic, predominantly diastolic, and mixed dysfunction.

View Article and Find Full Text PDF
Article Synopsis
  • * HFpEF has a prognosis similar to HFrEF, but effective therapies for HFpEF are limited compared to those available for HFrEF.
  • * The European Association of Cardiovascular Imaging (EACVI) has released guidelines for diagnosing elevated left ventricular filling pressure and using multimodality imaging to identify specific causes of HFpEF.
View Article and Find Full Text PDF
Article Synopsis
  • The survey aimed to assess the use of echocardiography in pre-participation evaluations (PPE) for athletes and understand doctor beliefs and barriers affecting their practices.
  • Among 603 healthcare professionals from 97 countries, 65% reported using echocardiography regularly, primarily starting during adolescence, regardless of the athlete’s competitive level.
  • While many see echocardiography as a standard first-line screening tool, there is a lack of scientific evidence to support its widespread use, indicating the need for larger studies.
View Article and Find Full Text PDF

Heart failure (HF) is a highly prevalent clinical syndrome characterized by considerable phenotypic heterogeneity. The traditional classification based on left ventricular ejection fraction (LVEF) is widely accepted by the guidelines and represents the grounds for patient enrollment in clinical trials, even though it shows several limitations. Ejection fraction (EF) is affected by preload, afterload, and contractility, it being problematic to express LV function in several conditions, such as HF with preserved EF (HFpEF), valvular heart disease, and subclinical HF, and in athletes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!